Welcome to our dedicated page for Origin Agritech news (Ticker: SEED), a resource for investors and traders seeking the latest updates and insights on Origin Agritech stock.
Origin Agritech Limited develops agricultural technology and crop seed biotechnology in China, with news centered on corn seed R&D, genetic improvement, commercialization programs, and regulatory authorizations for crop seed production and GMO-related operations. Company updates frequently cover new corn varieties such as Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728, as well as distributor initiatives including the Golden Harvest Club.
Recurring developments also include biotechnology pipeline work involving glyphosate tolerance, Bt pest-resistance traits, phytase corn, gene editing technology, research collaborations, market expansion in Chinese agricultural regions, annual results, financing actions, and board or finance leadership changes.
Origin Agritech (NASDAQ: SEED) will release first half fiscal 2026 financial results on May 21, 2026. The company will host an earnings and business update conference call on May 22, 2026 at 8 a.m. ET, featuring its CEO and CFO, with phone and webcast access plus a two‑week replay.
Origin Agritech (NASDAQ: SEED) launched a redesigned corporate website on April 14, 2026 to better serve partners, customers, and investors. The site features a mobile-responsive design, faster load times, reorganized content around three stakeholder audiences, an expanded technology section, and a centralized Investor Relations center.
The redesign highlights R&D, GMO phytase corn and hybrid seed work, enhanced newsroom and partner resources, improved SEO and accessibility, and direct engagement channels for distributors, growers, and the global investment community.
Origin Agritech (NASDAQ: SEED) announced board and executive changes effective March 20, 2026: Dr. Jian Zhang joins as an independent director and Dr. Zheng James Chen returns as chief financial officer. Two executives resigned earlier in March 2026.
Appointments emphasize deep crop biotechnology R&D experience and financial continuity as Origin advances its commercial seed technology pipeline in China and international markets.
Origin Agritech (NASDAQ: SEED) launched the "Aoyun 2026" promotion program to accelerate commercialization of next-generation seed varieties ahead of China's spring planting season.
The initiative centralizes national sales strategy, appoints Weiwei Shi as General Commander, coordinates subsidiary deployment across major corn belts, advances GMO and gene-editing commercialization via a strategic alliance, and formalizes 2026–2027 performance accountability contracts after a sales team rebuild.
Origin Agritech (NASDAQ: SEED) reported fiscal 2025 results for the year ended September 30, 2025, including revenue of RMB 91.3 million (US$12.8M) and a net loss attributable to Origin of RMB 53.3 million (US$7.5M). The company cited Xinjiang factory upgrades as a primary driver of lower revenue.
Highlights include four new corn varieties, multiple regulatory approvals, expanded R&D platforms and germplasm resources, a restored Xinjiang processing line, cash of RMB 15.9 million, and increased financing inflows in fiscal 2025.
Origin Agritech (NASDAQ: SEED) will announce fiscal year 2025 financial results on Friday, January 30, 2026 and will host a business update and conference call on Monday, February 2, 2026 at 8:00 a.m. ET.
The conference call will be led by Weibin Yan, CEO, and Patrick Cheng, CFO. The company will also file its annual report on Form 20-F on January 30. Investors may submit written questions by January 29 via email to matthew@strategic-ir.com.
Dial-in access: 1-800-245-3047 (US) or 1-203-518-9765 (International) using conference ID ORIGIN. A live webcast is available at the provided webcast link and a replay will be available for two weeks.
Origin Agritech (NASDAQ: SEED) held its Annual R&D and Operations Management Conference in Beijing from November 22–24, 2025 to review FY2025 performance and set priorities for 2026.
The three-day session united senior management, subsidiary leaders, and academic experts to formalize a core-values framework (the ORIGIN acronym) and prioritize: AI-integrated biological breeding, operational infrastructure optimization, and market expansion. Presentations reviewed R&D advances in precision breeding, AI-assisted breeding models, gene editing integration, and 2025 operational improvements. The company emphasized disciplined execution, resource optimization, and partnerships with leading Chinese agricultural research institutions to support growth in 2026.
Origin Agritech (NASDAQ: SEED) announced its Hi3 corn haploid induction gene-editing technology was selected as one of the Top 10 Major Progresses in Chinese Agricultural Science for 2025 by the Chinese Academy of Agricultural Sciences. The Hi3 system, published in Nature in June 2024, enables efficient, fixed-point editing across diverse maize inbred lines and can shorten trait improvement by 3–4 years versus conventional backcrossing.
Origin reports it has developed more than 10 improved induction lines targeting leaf angle, drought and lodging resistance, extended growth periods, and plans to advance commercial gene-edited corn varieties in the coming years.
Origin Agritech (NASDAQ: SEED) entered a patent license agreement with Shandong Shunfeng Biotechnology to access the Cas-SF01 gene editing platform, securing long-term IP rights for trait gene editing.
Together with China Agricultural University, Origin developed edited corn induction lines ZmRAVL1-KO1 and ZmDWF4-KO1 that optimize leaf angle to create a "smart plant architecture" for higher planting density and improved light interception. The company has started biosafety assessments and says final biosafety certification may require 1-2 years. The license also aims to support biosafety approval for transformants using Origin's Hi-3 one-step editing method, advancing its commercial hybrid breeding roadmap.
Origin Agritech (NASDAQ: SEED) announced on October 24, 2025 a set of regulatory and corporate moves to expand seed production and GMO capabilities in China. The company obtained a Beijing crop seed production and operation license authorizing production, processing, packaging, wholesale and retail of corn seeds, adding to a second existing license held by its subsidiary in Xinjiang.
Beijing Tongzhou authorities also approved the inclusion of GMO crop seed production in the company's business scope (individual GMO crop registrations remain required). Origin raised the registered capital of Beijing Origin Seed from RMB 30 million to RMB 100 million and consolidated key production and sales entities under Beijing Origin as its primary operational hub.